Hif1α is required for osteoclast activation and bone loss in male osteoporosis

Biochemical and Biophysical Research Communications
Toshimi TandoTakeshi Miyamoto

Abstract

The number of osteoporosis patients is increasing not only in women but in men. Male osteoporosis occurs due to aging or androgen depletion therapies, leading to fractures. However, molecular mechanisms underlying male osteoporosis remain unidentified. Here, we show that hypoxia inducible factor 1 alpha (Hif1α) is required for development of testosterone deficiency-induced male osteoporosis. We found that in mice Hif1α protein accumulates in osteoclasts following orchidectomy (ORX) in vivo. In vitro, Hif1α protein accumulated in osteoclasts cultured in hypoxic conditions, but Hif1α protein rather than mRNA levels were suppressed by testosterone treatment, even in hypoxia. Administration of a Hif1α inhibitor to ORX mice abrogated testosterone deficiency-induced osteoclast activation and bone loss but did not alter osteoclast activities or bone phenotypes in sham-operated, testosterone-sufficient animals. We conclude that Hif1α protein accumulation due to testosterone-deficiency promotes development of male osteoporosis. Thus Hif1α protein could be targeted to inhibit pathologically-activated osteoclasts under testosterone-deficient conditions to treat male osteoporosis patients.

References

May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·H YasudaT Suda
Jun 18, 1999·The Journal of Clinical Endocrinology and Metabolism·P J SnyderB L Strom
Aug 15, 2001·The Journal of Clinical Endocrinology and Metabolism·S KhoslaW M O'Fallon
Jan 5, 2002·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Colleen ChristmasMarc R Blackman
May 26, 2004·Archives of Internal Medicine·Ethel S SirisMarc L Berger
Jul 20, 2006·The Journal of Clinical Endocrinology and Metabolism·Howard A FinkEric S Orwoll
Mar 14, 2007·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Nguyen D NguyenTuan V Nguyen
Apr 4, 2008·The New England Journal of Medicine·Peter R Ebeling
May 3, 2008·Endocrine Reviews·Sundeep KhoslaEric Orwoll
May 29, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Michael P WhyteDeborah Wenkert
Jun 5, 2008·The Journal of Clinical Endocrinology and Metabolism·Maja VisekrunaFergus Eoin McKiernan
Aug 22, 2008·The New England Journal of Medicine·Susan M Ott
Sep 30, 2008·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Lourdes BasurtoRosa Galván
Nov 26, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·Jean M Kaufman, Stefan Goemaere
Feb 5, 2009·JAMA : the Journal of the American Medical Association·Dana BliucJacqueline R Center
Aug 13, 2009·The New England Journal of Medicine·Steven R CummingsUNKNOWN FREEDOM Trial
Sep 15, 2009·International Journal of Epidemiology·Noriko YoshimuraToru Akune
Mar 17, 2010·Annals of Internal Medicine·Patrick HaentjensSteven Boonen
Jun 16, 2010·Experimental Hematology·Amélie V GuitartVincent Praloran
Jul 2, 2010·The New England Journal of Medicine·Shehzad BasariaShalender Bhasin
Oct 12, 2010·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Sundeep KhoslaB Lawrence Riggs
Oct 12, 2010·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C S RyanR A Adler
Oct 19, 2011·The Journal of Experimental Medicine·Kana MiyamotoTakeshi Miyamoto
May 19, 2012·Trends in Endocrinology and Metabolism : TEM·Sundeep KhoslaDavid G Monroe
Feb 15, 2013·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Lydia GedmintasSeoyoung C Kim
Mar 20, 2013·Nature Reviews. Rheumatology·Robert E ColemanJanet E Brown
May 31, 2013·Current Opinion in Rheumatology·Peter R Ebeling
Jun 13, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Nelson B Watts
Sep 11, 2013·Nature Reviews. Endocrinology·Jennifer S Walsh, Richard Eastell
Sep 12, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yoshiteru MiyauchiTakeshi Miyamoto
Nov 1, 2013·Endocrine·Annie-Claude M LassemillanteOlivia R L Wright
Apr 15, 2014·Clinical Biochemistry·Nichole Korpi-SteinerCatherine Hammett-Stabler

❮ Previous
Next ❯

Citations

Dec 16, 2016·Biochemical and Biophysical Research Communications·Yuiko SatoTakeshi Miyamoto
Mar 6, 2019·Current Osteoporosis Reports·Betsabel ChicanaJennifer O Manilay
Jul 10, 2020·Journal of Cellular Physiology·Scott S HannahConor McClean
Apr 6, 2021·Frontiers in Cell and Developmental Biology·Xianyi MengAline Bozec
Aug 7, 2021·Biomedicines·Christian KirschneckAgnes Schröder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved